The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Channel 2 Consumer Advisor Clark Howard said families whose income qualifies should look for drug discounts that are provided ...

Lilly is expected to apply for FDA approval for an oral diabetes medication within the year and will likely apply to market the medication as a weight loss drug shortly thereafter. After Lilly’s ...

These are referred to as compounded drugs, which, while containing some of the same ingredients, are not identical to the ...

Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral ...

Also In This Package How fasting helps in sustainable weight loss Don't skip ... Tirzepatide was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound) and in the ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Get weight loss medications through licensed medical providers to ensure you get FDA-approved, properly dosed products. Jump to insight Prepare for medical appointments with your health history ...

Wegovy, Ozempic and Zepbound are normally used to help shed some pounds, but experts said that can come at a cost for those ...